These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38182001)

  • 1. The effects of medication therapy management on medication utilization among Medicare beneficiaries with HIV/AIDS.
    Zhang X; Wang J
    J Am Pharm Assoc (2003); 2024; 64(2):463-470.e2. PubMed ID: 38182001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should eligibility for medication therapy management be based on drug adherence?
    Stuart B; Loh E; Miller L; Roberto P
    J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.
    Spivey CA; Qiao Y; Wang J; Shih YT; Wan JY; Dagogo-Jack S; Cushman WC; Hines LE; Chisholm-Burns MA
    J Am Geriatr Soc; 2019 Mar; 67(3):581-587. PubMed ID: 30674080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
    Lee JS; Yang J; Stockl KM; Lew H; Solow BK
    J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
    Welch EK; Delate T; Chester EA; Stubbings T
    Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up.
    Moczygemba LR; Barner JC; Lawson KA; Brown CM; Gabrillo ER; Godley P; Johnsrud M
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):328-38. PubMed ID: 21865093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
    Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB
    J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728
    [No Abstract]   [Full Text] [Related]  

  • 15. The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease.
    Zhang X; Sim Y; Tsang CCS; Wang J; Finch CK
    Explor Res Clin Soc Pharm; 2024 Sep; 15():100470. PubMed ID: 39050144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Medicare Part D comprehensive medication review on medication adherence among patients with Alzheimer's disease.
    Dong X; Tsang CCS; Zhao S; Browning JA; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Hines LE; Wang J
    Curr Med Res Opin; 2021 Sep; 37(9):1581-1588. PubMed ID: 34039232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
    Almodóvar AS; Nahata MC
    J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groups.
    Tsang CCS; Wang J; Shih YT
    Medicine (Baltimore); 2024 May; 103(18):e37935. PubMed ID: 38701304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.
    Lu D; Qiao Y; Johnson KC; Wang J
    J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.